Isotope labelled Pasireotide. Pasireotide is a synthetic long-acting cyclic hexapeptide with somatostatin-like activity. It is marketed as a diaspartate salt called Signifor®, which is used in the treatment of Cushing's disease.
CAT No:10-101-197
CAS No:396091-73-9 (non-labelled)
Synonyms/Alias:Cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl]-d7; SOM 230-d7SOM 320-d7; Signifor-d7;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C₅₈H₅₉D₇N₁₀O₉ |
M.W/Mr. | 1054.25 |
Sequence | Cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl]-d7 |
Labeling Target | Somatostatin receptor |
Application | Pasireotide-d7 is invesgated for the treatment of Cushing's disease, specifically for those patients whom pituitary surgery has not been curative or is not an option. |
Purity | 98.0 % min |
Functions | Somatostatin receptor activity |
Organism | Human |
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.